The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels
Abstract Introduction: Cannabidiol (CBD) has been clinically approved for intractable epilepsies, offering hope that novel anticonvulsants in the phytocannabinoid class…